FILE PHOTO: NAFDAC Workplace, Abuja.
The Nationwide Company for Meals and Drug Administration and Management (NAFDAC) has accredited the manufacturing of Chloroquine for medical trials within the seek for a treatment for COVID-19.
Director-Common of the company, Mojisola Adeyeye, made the announcement on Friday on the NAFDAC headquarters in Lagos.
She, nonetheless, identified that NAFDAC will not be approving Chloroquine for the remedy of COVID-19 however for medical trials to search out remedy for the virus.
READ ALSO: FG Orders Shutdown Of Three Worldwide Airports
“NAFDAC will not be approving Chloroquine as a product that has can be utilized for Coronavirus as a result of there isn’t any submission to us for registration however as a result of it’s beneath medical trials, NAFDAC approves medicines meant for medical trials.
“Due to this fact the medication is being accredited only for the medical trials,” Adeyeye stated.
She, due to this fact, referred to as on specialists and researchers which might be fascinated by doing a medical trial on Chloroquine to strategy accredited retailers.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of clinical trial,” Adeyeye added.